Introduction
The histidine triad proteins are a large and highly conserved family of proteins characterized as having the conserved sequence H'H'H/Q' (where ' is any hydrophobic amino acid). This family of proteins can be classified into three groups based upon sequence, substrate specificity, structure and mechanism: (i) the HINT branch, which consists of adenosine 5 0 -monophosphoramide hydrolases, (ii) the Fhit branch, which consists of diadenosine polyphosphate hydrolases, and (iii) the GalT branch, which consists of specific nucleoside monophosphate transferases (Brenner, 2002) . At least one human representative is lost in some diseases. For example, apraxin, a HINT family member, is lost in ataxiaoculomotor apraxia syndrome, Fhit is lost in the development of epithelially derived tumors and GalT is lost in galactosemia (Brenner et al., 1997; Brenner, 2002) .
The Seattle Structural Genomics Center for Infectious Disease (SSGCID) protein EnhiA.01296.a (EhHIT) was originally identified in the Entamoeba histolytica genome in 2005 (Loftus et al., 2005) as a hypothetical protein called EHI_093910 and given GenBank accession XP_655618. The target was one of 1477 eukaryotic pathogens selected by SSGCID based on sequence similarity to protein targets in the DrugBank database (Wishart et al., 2008; Myler et al., 2009; Stacy et al., 2011; Phan et al., 2014) . Genes from several eukaryotic genomes, including E. histolytica, were used in a BLAST search against DrugBank and those that showed >50% similarity over >75% of their length were passed to the next filter. Additional filters included a rigorous screen of physical properties to filter out those with unreasonable sizes or amino-acid compositions or with the presence of trans-
# 2015 International Union of Crystallography membrane domains or low-complexity sequences, which are associated with difficulty in soluble expression and crystallization. Additionally, targets with close similarity to sequences already in the PDB or already targeted by other structural genomics groups were removed (Myler et al., 2009) . For EhHIT, XtalPred-EP gives a score of three out of five for likelihood of crystallizability, which is average for a protein of this size (Slabinski et al., 2007) . Similarly, XtalPred-RF gives a score of four out of 11 or slightly better than average crystallizability. No transmembrane domains were predicted by TMpred (Hofmann & Stoffel, 1993) . Based upon sequence similarity only, this target appears to be in the HINT branch of the HITs. We initially determined the structure of the apo protein, which had a molecule of sulfate in its active site, and we then co-crystallized this target with AMP and GMP. Here, we present the sulfate-bound structure and the two nucleotide-bound structures.
Materials and methods

Macromolecule production
The target gene was PCR-amplified using Phusion DNA polymerase (New England Biolabs) and suitable primers (GGGTCCTGGTTCGATGGCTGATTCATGCATTTTCTG-TA and CTTGTTCGTGCTGTTTATTATAATTTATCCC-AAGCAAGTTTTTTTCC), with E. histolytica HM-1:IMSS cDNA as the template (Table 1 ). The PCR product was gelpurified, treated with T4 DNA polymerase and annealed via ligation-independent cloning (LIC) to the AVA0421 vector, a T7 expression vector containing a cleavable six-histidine tag at the N-terminus (Choi et al., 2011) . The LIC-annealed construct was propagated in Escherichia coli NovaBlue competent cells (EMD Biosciences) and subsequently transformed into the E. coli Rosetta Oxford BL21(DE3)R3 expression host strain for expression testing. After transformation into the expression host, a starter culture from a single colony in LB broth was grown for $18 h at 310 K. Protein was expressed in a LEX bioreactor in the presence of 50 mg ml À1 ampicillin, 50 mg ml À1 carbenicillin and 34 mg ml À1 chloramphenicol in 2 l ZYP-5052 auto-induction medium (Studier, 2005) . The culture was grown for 24 h at 298 K and was then incubated for a further 60 h at 288 K. The cells were collected by centrifugation at 4000g for 20 min at 277 K. The cell paste was stored frozen at 193 K. The frozen E. coli cell-paste pellet was lysed in 200 ml lysis buffer (0.3 M NaCl, 20 mM HEPES pH 7.4, 5% glycerol, 30 mM imidazole, 0.5% CHAPS, 2 mM MgCl 2 ) with lysozyme, five tablets of Roche protease-inhibitor cocktail and 250 ml 14.3 M -mercaptoethanol. The suspension was sonicated for 45 min with a pulse frequency of 5 s on, 10 s off. The lysate was incubated with 20 ml Benzonase for 40 min at room temperature and clarified by centrifugation for 60 min at 15 200g in a Sorvall SLA-1500 rotor. The lysate was filtered using a 0.45 mm low-protein-binding filter and loaded onto a 5 ml HisTrap FF column (GE Healthcare, Piscataway, New Jersey, USA). The protein was eluted with an 80 ml gradient of 0-100% buffer B (30-500 mM imidazole). Fractions containing the target protein were pooled and concentrated for size-exclusion chromatography (SEC). The protein was loaded onto a HiLoad 26/60 Superdex preparative-grade SEC column (GE Healthcare, Piscataway, New Jersey, USA) and run in a buffer consisting of 0.3 M NaCl, 20 mm HEPES pH 7.0, 5% glycerol, 1 mM TCEP at 1.5 ml min À1 ; 2.5 ml fractions were collected. The protein eluted at a volume consistent with a monomer. The fractions containing the target protein were pooled, concentrated to 83.24 mg ml À1 , flash-frozen in 200 ml aliquots in liquid nitrogen and stored at 193 K. Protein concentrations were determined using a Nanodrop ND-1000 (Thermo Fisher Scientific, Waltham, Massachusetts, USA).
Crystallization
All crystallization experiments were set up as sitting-drop vapour-diffusion trials using XJR Junior crystallization trays (Rigaku Reagents). The drops were formed by mixing 0.4 ml protein solution with 0.4 ml precipitant solution and were incubated against 80 ml reservoir solution at 289 K. Crystallization conditions were searched for using the commercial screens JCSG+ (Rigaku Reagents) and PACT (Molecular Dimensions). Crystallization conditions for EhHIT at 83.2 mg ml À1 were as follows: EhHIT + sulfate, JCSG+ condition A1 (50% PEG 400, 0.1 M acetate buffer pH 4.5, 200 mM Li 2 SO 4 ), direct cryocooling; EhHIT + AMP, JCSG+ condition B6 [40%(v/v) ethanol, 5%(w/v) PEG 1000, phosphate-citrate buffer pH 4.2, 10 mM AMP], cryopreserved with 20% ethylene glycol; EhHIT + GMP, JCSG+ condition B6 [40%(v/v) ethanol, 5%(w/v) PEG 1000, phosphate-citrate buffer pH 4.2, 10 mM AMP], cryopreserved with 20% ethylene glycol. All crystals were incubated for several seconds in the cryosolution and vitrified by plunging them into liquid nitrogen.
Data collection and processing
The diffraction data set for the EhHIT + sulfate crystal was collected on ALS beamline 5.0.3 with an ADSC Quantum 315 CCD detector. The diffraction data sets for the EhHIT + AMP and EhHIT + GMP crystals were collected in-house with a Rigaku FR-E+ SuperBright generator using a Rigaku 944+ CCD detector. All data sets were collected at 100 K. The Table 1 Macromolecule-production information.
Source organism E. histolytica DNA source E. histolytica strain HM-1:IMSS, genomic DNA Forward primer
GGGTCCTGGTTCGATGGCTGATTCATGCATTTTC-TGTA
Reverse primer
CTTGTTCGTGCTGTTTATTATAATTTATCCCAAG-CAAGTTTTTTTCC
Cloning vector AVA0421 Expression vector AVA0421, IPTG or lactose inducible Expression host E. coli Rosetta Oxford BL21(DE3)R3 Complete amino-acid sequence of the construct produced
GPGSMADSCIFCKIAQKQIPSTIVYEDDEIFAFK-DINPIAPIHILVIPKQHIASLNEITEENEAFI-GKVLYKVSLIGKKECPEGYRVVNNIGEDAGQT-VKHIHFHILGGKKLAWDKL
X-ray data were reduced with XDS and XSCALE. Details of the data collections are summarized in Table 2 .
Structure solution and refinement
The structures were solved by molecular replacement using Phaser (McCoy et al., 2007) . PDB entry 1xqu (Southeast Collaboratory for Structural Genomics, unpublished work) was used as the search model for the EhHIT + sulfate stucture;
the EhHIT + sulfate structure (PDB entry 3oj7) was used as the model for EhHIT + AMP, and the EhHIT + AMP structure (PDB entry 3omf) was used as the model for EhHIT + GMP. Reciprocal-space refinement was performed with REFMAC using TLS (Murshudov et al., 2011) in iterative cycles of model building using Coot (Emsley & Cowtan, 2004) . The models contained almost the entire length of the protein: residues 4-113 for EhHIT + sulfate, residues 3-113 for EhHIT + AMP and residues À2 to 113 for EhHIT + GMP. PDB codes for the three structures are given in Table 3 .
Results and discussion
The E. histolytica protein EnhiA.01296.a (EhHIT) is a classic example of a HIT protein with the signature motif H'H'H'', in this case His-Ile-His-Phe-His-Ile-Leu, with the first histidine located 17 amino acids from the C-terminus at residue 97. By sequence analysis this protein appears to belong to the HINT branch of the HIT family. EhHIT is similar in amino-acid sequence to proteins that have been given the designation protein kinase C inhibitor-1 (PKCI-1). This HINT branch has also been identified to contain purine nucleoside-and nucleotide-binding proteins (Brenner et al., 1997; Brenner, 2002) . This target was predicted by XtalPred (Slabinski et al., 2007) to have average or slightly better than average crystallizability, with no other physical or sequence elements thought to inhibit crystallization. With this in mind, we set up initial 
Figure 1
Overlay of three EhHIT structures. The models are presented as carton renderings with the sulfate-bound structure (PDB entry 3oj7) in green, the AMP-bound structure (PDB entry 3omf) in cyan and the GMP-bound structure (PDB entry 3oxk) in magenta. The AMP in PDB entry 3omf is shown as sticks and the Zn 2+ ion is shown as a grey sphere. The pairwise r.m.s.d.s are 0.111 Å for 3oj7 versus 3omf, 0.133 for 3oj7 versus 3oxk and 0.064 Å for 3omf versus 3oxk. The overlay and pairwise scores were generated in PyMOL.
apo crystallization trials using only two commercial crystallization screens: JCSG+ and PACT. Based upon the proposed sequence similarity to the HINT branch, the initial apo trials were followed up with co-crystallizations with the purine monophosphate nucleotides AMP and GMP. The three models overlay with very small r.m.s.d.s (Fig. 1) . In all three structures the Zn 2+ ion is coordinated by Cys5, Cys8, His47 and His97 (Fig. 2a) . We identified the metal ion as Zn 2+ based on other HINT structures such as PDB entry 1kpa (Lima et al., 1996) . Additionally, we used CheckMyMetal (http://csgid.org/csgid/metal_sites/) to confirm the assignment of Zn 2+ . In the sulfate-bound structure the sulfate is coordinated by Asn86, Thr94, His99 and His101 (Fig. 2b) . In the AMP-bound structure the phosphate is coordinated by the same residues as the sulfate, Asn86, Thr94, His99 and His101, while the ribose and adenine are further coordinated by Asp31 and Asn32 (Fig. 2c) . Similarly, for the GMP-bound structure the phosphate, ribose and guanosine of GMP make the same contacts as AMP, with one additional contact between the backbone carbonyl of Lys30 and the 2-amino group of guanosine (Fig. 2d) . In both the AMP-bound and GMP-bound structures the Watson-Crick face of the purine makes water-mediated contacts with the protein, the opposite face is solvent-exposed and the sugar edge makes direct contacts with the protein.
